Abstract
Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Abdominal Neoplasms, Date of authorisation: 19/09/2019, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have